• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Can clinical trials be reinvented?

Can clinical trials be reinvented?

May 16, 2016
CenterWatch Staff

Over the last few years, I have been involved in several initiatives related to strengthening the sustainability and reducing the burden of sites around the globe. This momentum is growing through associations working on behalf of sites such as the Alliance for Clinical Research Excellence and Safety (ACRES), the Association of Clinical Research Professionals (ACRP), the Society of Clinical Research Sites (SCRS), the Collaborative Institutional Training Initiative (CITI), TransCelerate and others.

2016 is the year of the site. Advisory groups of site personnel are forming worldwide, and sponsored by pharma, CROs and others. Special meetings designed to address the perceptions and issues facing sites are virtually everywhere. Research sites around the world have many faces, different scales and various models of delivery. It bears thinking about how any clinical research site, large or small, can stay informed of this activity and become involved and as knowledgeable as possible.

I would like to highlight some solutions being developed. In many cases, sites are either uninformed or misinformed. I believe it is critical for sites to better understand the unique attributes of organizations like TransCelerate undertake on behalf of sites and patients. Those who are making an effort to reinvent clinical trials cannot do so without representing the site perspective.

cww2019_20160516_Q1lMQb-pulse

TransCelerate BioPharma is a nonprofit organization dedicated to improving the health of people around the world by accelerating and enhancing the R&D of innovative new therapies. The organizations’ mission is to collaborate across the global biopharmaceutical R&D community to identify, prioritize, design and facilitate the implementation of solutions designed to drive efficient, effective and high-quality delivery of new medicines.

Two site-facing initiatives in particular that have been spearheaded by TransCelerate are:

  • Investigator Registry, which enhances TransCelerate’s Shared Investigator Platform and accelerates identification and recruitment of qualified investigators in order to avoid duplication of standard sites.
  • Shared Investigator Platform,which facilitates interaction between investigators and multiple clinical trial sponsors, enabling study planning, study startup and study conduct activities, while reducing the administrative burden on the site staff.

Christine Pierre, president of SCRS, has worked with TransCelerate on a number of programs. For example, TransCelerate has supported up to five SCRS Site Advisory Groups per year over the last two years. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability.

Other site advocacy initiatives are supported by ACRP. For over 30 years, they have provided global leadership to promote integrity and excellence for clinical researchers. ACRP is a nonprofit organization with over 13,000 members in 70 countries.

ACRES strives to align good business practices and good ethical practices to enhance safety, quality, efficiency and professionalism in clinical trials. Research sites can register to become an ACRES-affiliated site by registering online.

The CITI program promotes the public’s trust in the research enterprise and aims to provide high-quality, peer-reviewed, web-based, research education materials to enhance the integrity and professionalism of investigators and staff conducting research.

The growing demands on sites today are clearly being recognized by industry as untenable. It is with serious intent that I reinforce that 2016 truly can be the year that sites are on the map permanently. These organizations include site involvement to help the industry on new clinical trial delivery methods, and quality and structure for an industry that cannot function without the investigator site.

This growing portfolio of organizations may warrant your interest and follow-up.   

 

Dr. Christophe Berthoux has been the chief executive officer at Synexus since September 2010. Synexus is the world’s leading site management organization (SMO), dedicated to the recruitment and management of clinical trials across the globe for over 24 years. Synexus is proud to be the patient’s choice for clinical research. Email comments and questions to sarah@vanepercy.com.

This article was reprinted from CWWeekly, a leading clinical research industry newsletter providing expanded analysis on breaking news, study leads, trial results and more. Subscribe »

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing